Finų medis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,293,009 | 5,864,760 | 6,266,643 | 8,554,720 | 10,273,671 | 10,697,419 | 11,511,796 | 12,653,850 |
| Profit before tax | 177,775 | 279,960 | 173,146 | 704,394 | 590,698 | 417,472 | 415,691 | 620,119 |
| Net profit | 148,383 | 234,502 | 143,937 | 596,655 | 499,722 | 356,664 | 350,661 | 532,919 |
| Equity | 563,255 | 722,758 | 647,774 | 1,145,572 | 1,386,748 | 1,543,412 | 1,694,073 | 2,076,992 |
| Liabilities | 1,126,698 | 1,037,395 | 1,111,066 | 1,126,461 | 1,433,876 | 1,553,221 | 1,422,935 | 1,532,102 |
| Non-current assets | 286,834 | 268,667 | 608,111 | 636,378 | 738,591 | 722,217 | 539,667 | 949,237 |
| Current assets | 1,399,647 | 1,489,039 | 1,147,678 | 1,633,337 | 2,079,547 | 2,370,958 | 2,574,696 | 2,651,153 |
| Total assets | 1,686,481 | 1,757,706 | 1,755,789 | 2,269,715 | 2,818,138 | 3,093,175 | 3,114,363 | 3,600,390 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,389,621 | 2,490,969 | 2,705,972 |
| Social insurance contributions | - | - | - | - | - | 261,136 | 288,883 | 323,498 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +29.8% | +10.8% | +6.9% | +36.5% | +20.1% | +4.1% | +7.6% | +9.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.8% | 13.3% | 8.2% | 26.3% | 17.7% | 11.5% | 11.3% | 14.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 26.3% | 32.4% | 22.2% | 52.1% | 36.0% | 23.1% | 20.7% | 25.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.8% | 4.0% | 2.3% | 7.0% | 4.9% | 3.3% | 3.0% | 4.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.4% | 4.8% | 2.8% | 8.2% | 5.7% | 3.9% | 3.6% | 4.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.0 | 1.4 | 1.7 | 1.0 | 1.0 | 1.0 | 0.8 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 260,312 | 255,916 | 224,476 | 281,251 | 315,305 | 325,810 | 327,349 | 345,105 |
Sales revenue
Consolidated Finų medis finance
|
EUR
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 13,852,757 | 15,118,895 | 17,229,204 |
| Profit before tax | 555,650 | 671,961 | 1,140,917 |
| Net profit | 472,137 | 563,927 | 1,013,238 |
| Equity | 1,950,881 | 2,314,808 | 3,183,539 |
| Liabilities | 2,114,021 | 2,097,431 | 2,697,567 |
| Non-current assets | 893,702 | 907,995 | 2,324,835 |
| Current assets | 3,164,779 | 4,015,075 | 4,038,015 |
| Total assets | 4,058,481 | 4,923,070 | 6,362,850 |
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Finų medis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-02-17 | 2022-03-01 | 17.66 |
| 2022-01-31 | 2022-02-14 | 17.66 |
Finų medis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-25 | 2025-10-25 | 121.07 |
| 2025-10-24 | 2025-10-24 | 121.0 |
| 2025-03-27 | 2025-03-27 | 6.18 |
| 2025-03-22 | 2025-03-24 | 1044.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Finu medis, UAB (code 126365772) is a Private Limited Liability Company engaged in wholesale of wood, construction materials and sanitary equipment. In 2025, the company generated revenue of €12.65M and net profit of €532.9K, up from €11.51M revenue and €350.7K profit in 2024. This followed €10.70M revenue and €356.7K net profit in 2023, showing a steady three-year increase in sales and a clear improvement in profitability in the latest year. The 2025 profit margin was 4.2%, compared with 3.0% in 2024 and 3.3% in 2023. The latest revenue growth was 9.9% year on year and 18.3% over two years. At year-end 2025, total assets stood at €3.60M, equity at €2.08M and liabilities at €1.53M. Key ratios indicate a solid capital structure, with an equity ratio of 57.7%, debt-to-equity of 0.74 and asset turnover of 3.51x. Return on equity was 25.7% and return on assets 14.8%. Revenue per employee reached €351.5K in 2025.